无症状个体结直肠癌发生预测模型的比较:系统文献综述及在EPIC与UK Biobank前瞻性队列中的外部验证
该研究通过更新系统综述识别了16个无需侵入性检测的结直肠癌风险预测模型,并在EPIC和UK Biobank两个大型前瞻性队列中进行外部验证。验证样本量从41 587至396 515例不等,病例数从115至1 781例。模型校准良好,区分度相似,最高C统计量在UK Biobank为0.70(95%CI 0.68至0.72),在EPIC为0.71(95%CI 0.67至0.74)。
要点
- 系统综述更新共识别16个非侵入性结直肠癌风险预测模型,来自8篇文献。
- 外部验证显示模型校准良好,重新校准后进一步改善,区分度在各队列间大致相似。
- 最高C统计量在UK Biobank为0.70(95%CI 0.68至0.72),在EPIC为0.71(95%CI 0.67至0.74)。
核心结论
- 多个非侵入性模型在两个外部验证人群中表现出良好的校准和区分度,可能适合用于人群结直肠癌筛查中的风险分层。
- 未来工作应通过建模和影响研究评估这一潜力,并确定能否进一步提升模型性能。
研究设计与样本
- 通过更新已发表的系统综述识别模型,并在欧洲癌症与营养前瞻性调查(EPIC)和UK Biobank两个大型人群前瞻性队列中进行外部验证。
- 每个模型验证纳入的参与者数从41 587至396 515例不等,病例数从115至1 781例。
- 通过C统计量评估区分度,通过观测概率与预测概率图评估校准度,预测研究入组后5年或10年内结直肠癌的发生。
主要发现
- 系统综述及其更新从8篇文献中识别出16个模型(8个结直肠癌、5个结肠癌和3个直肠癌模型)。
- 在各模型验证中,符合条件与不符合条件的参与者大致可比。
- 在可评估的模型中校准度非常好,重新校准后进一步改善。
- 各模型在验证队列间的C统计量大致相似,最高值在UK Biobank为0.70(95%CI 0.68至0.72),在EPIC为0.71(95%CI 0.67至0.74)。
局限性
- 未来工作应通过建模和影响研究评估这些模型在人群筛查中风险分层的潜力,并确定能否进一步提升模型性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically identify and validate published colorectal cancer risk prediction models that do not require invasive testing in two large population-based prospective cohorts. DESIGN: Models were identified through an update of a published systematic review and validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) and the UK Biobank. The performance of the models to predict the occurrence of colorectal cancer within 5 or 10 years after study enrolment was assessed by discrimination (C-statistic) and calibration (plots of observed vs predicted probability). RESULTS: The systematic review and its update identified 16 models from 8 publications (8 colorectal, 5 colon and 3 rectal). The number of participants included in each model validation ranged from 41 587 to 396 515, and the number of cases ranged from 115 to 1781. Eligible and ineligible participants across the models were largely comparable. Calibration of the models, where assessable, was very good and further improved by recalibration. The C-statistics of the models were largely similar between validation cohorts with the highest values achieved being 0.70 (95% CI 0.68 to 0.72) in the UK Biobank and 0.71 (95% CI 0.67 to 0.74) in EPIC. CONCLUSION: Several of these non-invasive models exhibited good calibration and discrimination within both external validation populations and are therefore potentially suitable candidates for the facilitation of risk stratification in population-based colorectal screening programmes. Future work should both evaluate this potential, through modelling and impact studies, and ascertain if further enhancement in their performance can be obtained.
引用
- Smith T, Muller DC, Moons KGM, et al. Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies. Gut. 2018. PMID: 29615487. doi:10.1136/gutjnl-2017-315730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。